Dexmedetomidine to Reduce the Incidence of POCD After Open Cardiac Surgery

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

August 9, 2018

Primary Completion Date

July 31, 2026

Study Completion Date

December 31, 2026

Conditions
DeliriumPostoperative Cognitive DysfunctionDexmedetomidineCognitive ImpairmentDepression
Interventions
DRUG

Dexmedetomidine Hydrochloride Group

Dexmedetomidine will be initiated prior to transfer to the CVICU with loading dose of 1 ug kg-1 over approximately 20 minutes. This will be followed by an infusion at 0.1-1.0 ug kg-1h-1 in CVICU for up to 24 hours from the time DEX infusion started or until the patient is ready for discharge from the CVICU (whichever is earlier).

Trial Locations (1)

M4N 3M5

Sunnybrook Health Sciences Centre, Toronto

All Listed Sponsors
lead

Sunnybrook Health Sciences Centre

OTHER